Natera Stock: A Genetic Investment Worth Watching And Holding (NASDAQ:NTRA)

1 min read
16 views

This article was written by

Ex- Management Consultant at BCG & McKinsey | CFA L3 | Value Investor since 2009 |I am a Dubai based active investor in equity markets since 2009, and my investment philosophy involves investing in value stocks which are trading at a discount to their intrinsic value. I am also a strong believer in assessing macro trends and sectoral themes to identify cyclical and seasonal plays (Long + Short)- which has rewarded me handsomely in the past.My educational background involves having an MBA from Indian Institute of Management (IIM) with specialization in Finance. I have also completed all levels of the CFA. From a professional journey, I started my career in the shipping industry, and then moved to McKinsey as a professional focused on financial institutions (Banks, insurance companies and asset managers). I then worked as a Management Consultant at Boston Consulting Group (BCG) and got exposure to a wide variety of sectors, including tech, pharma, oil and gas, manufacturing/ industrials to name a few. Right now, I am working as a Product Lead at Amazon- giving me good exposure to big tech and some of the most compelling technological trends like AI which are shaping the world.Investing and researching stocks is my hobby, and I believe in doing in-depth research on stocks which I would probably buy (or short). This involves me first using a set of pre-determined screens (Valuation metrics, insider buys etc.) to assess attractive opportunities, and then diving deep into the stock’s fundamentals to take the final buy/sell/ hold decision.

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, but may initiate a beneficial Long position through a purchase of the stock, or the purchase of call options or similar derivatives in NTRA over the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Read the full article here

Leave a Reply

Your email address will not be published.

Previous Story

72 Monthly Paid Dividend Stocks And 80 Funds For October

Next Story

2 Very Overrated And 2 Very Underrated Big Dividend Stocks

Latest from News